Home › Funds › Royce & Associates › ADMA
Royce & Associates position in ADMA
ADMA BIOLOGICS INC · Health Care
Latest position (Q1 2026)27.12K sh
Reported value held$244.39K
Portfolio Weight0.00%
First reportedQ4 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 420.57K | $7.21M | New |
| Q1 2025 | 697.00K | $13.83M | Add |
| Q2 2025 | 639.25K | $11.64M | Reduce |
| Q3 2025 | 932.07K | $13.66M | Add |
| Q4 2025 | 1.23M | $22.52M | Add |
| Q1 2026 | 27.12K | $244.39K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ADMA
- Vanguard Group 20.85M sh · $380.39M · Q4 2025
- BlackRock Inc 38.36M sh · $321.04M · Q2 2026
- Capital Research Global Investors 8.76M sh · $73.29M · Q2 2026
- Geode Capital Management 6.06M sh · $50.73M · Q2 2026
- D. E. Shaw & Co 5.27M sh · $44.15M · Q2 2026
- Goldman Sachs Group 3.51M sh · $29.41M · Q2 2026
- Northern Trust Corp 2.42M sh · $20.22M · Q2 2026
- Morgan Stanley 2.27M sh · $18.96M · Q2 2026
- Charles Schwab Investment Management 2.09M sh · $17.52M · Q2 2026
- Two Sigma Investments 2.02M sh · $16.91M · Q2 2026
- Bank of America Corp 1.65M sh · $13.79M · Q2 2026
- Citadel Advisors 1.62M sh · $13.56M · Q2 2026